BACKGROUND: Preoperative use of angiotensin-blocking drug therapy (ABDT) with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and its link to occurrence of postoperative atrial fibrillation (POAF), a common marker of poor outcomes after cardiac surgery, remain controversial. METHODS: From 1997 to 2003, 10,552 patients underwent coronary artery bypass grafting with or without valve surgery. To adjust for differences of clinical characteristics between patients who received ABDT within 24 hours before surgery compared with those who did not, propensity score analyses were conducted. RESULTS: Angiotensin-blocking drug therapy was prescribed in 4,795 (45%) before surgery, of which 1,725 (36%) developed POAF before discharge versus 1,908 (33%) of 5,757 patients who did not receive ABDT (unadjusted odds ratio 1.13, 95% CI 1.05-1.25, P < .01). In 6,744 propensity score-matched patients with well-balanced comorbidity profiles, ABDT was not associated with POAF (odds ratio 1.05, CI 0.95-1.16, P = .38). Stratified analysis within quintiles of propensity score and propensity-adjusted logistic multivariable regression confirmed these findings. CONCLUSIONS: In this large observational study, we found no evidence of an association between preoperative angiotensin blockade and the occurrence of POAF. Adequately powered randomized studies are needed to clarify the best strategy of perioperative ABDT in patients with and without guideline-based indications. Copyright 2010 Mosby, Inc. All rights reserved.
BACKGROUND: Preoperative use of angiotensin-blocking drug therapy (ABDT) with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and its link to occurrence of postoperative atrial fibrillation (POAF), a common marker of poor outcomes after cardiac surgery, remain controversial. METHODS: From 1997 to 2003, 10,552 patients underwent coronary artery bypass grafting with or without valve surgery. To adjust for differences of clinical characteristics between patients who received ABDT within 24 hours before surgery compared with those who did not, propensity score analyses were conducted. RESULTS: Angiotensin-blocking drug therapy was prescribed in 4,795 (45%) before surgery, of which 1,725 (36%) developed POAF before discharge versus 1,908 (33%) of 5,757 patients who did not receive ABDT (unadjusted odds ratio 1.13, 95% CI 1.05-1.25, P < .01). In 6,744 propensity score-matched patients with well-balanced comorbidity profiles, ABDT was not associated with POAF (odds ratio 1.05, CI 0.95-1.16, P = .38). Stratified analysis within quintiles of propensity score and propensity-adjusted logistic multivariable regression confirmed these findings. CONCLUSIONS: In this large observational study, we found no evidence of an association between preoperative angiotensin blockade and the occurrence of POAF. Adequately powered randomized studies are needed to clarify the best strategy of perioperative ABDT in patients with and without guideline-based indications. Copyright 2010 Mosby, Inc. All rights reserved.
Authors: Martin Osranek; Kaniz Fatema; Fatema Qaddoura; Ahmed Al-Saileek; Marion E Barnes; Kent R Bailey; Bernard J Gersh; Teresa S M Tsang; Kenton J Zehr; James B Seward Journal: J Am Coll Cardiol Date: 2006-07-25 Impact factor: 24.094
Authors: S F Aranki; D P Shaw; D H Adams; R J Rizzo; G S Couper; M VanderVliet; J J Collins; L H Cohn; H R Burstin Journal: Circulation Date: 1996-08-01 Impact factor: 29.690
Authors: Walter Palmas; Shuangge Ma; Bruce Psaty; David C Goff; Christine Darwin; R Graham Barr Journal: Am J Hypertens Date: 2007-03 Impact factor: 2.689
Authors: Stuart J Connolly; Irene Cybulsky; André Lamy; Robin S Roberts; Bernard O'brien; Sandra Carroll; Eugene Crystal; Kevin E Thorpe; Michael Gent Journal: Am Heart J Date: 2003-02 Impact factor: 4.749
Authors: Halil Ibrahim Ucar; Mustafa Tok; Enver Atalar; Omer Faruk Dogan; Mehmet Oc; Bora Farsak; Murat Guvener; Mustafa Yilmaz; Riza Dogan; Metin Demircin; Ilhan Pasaoglu Journal: Heart Surg Forum Date: 2007 Impact factor: 0.676
Authors: Mitchell J Magee; Morley A Herbert; Todd M Dewey; James R Edgerton; William H Ryan; Syma Prince; Michael J Mack Journal: Ann Thorac Surg Date: 2007-05 Impact factor: 4.330
Authors: Mias Pretorius; Katherine T Murray; Chang Yu; John G Byrne; Frederic T Billings; Michael R Petracek; James P Greelish; Steven J Hoff; Stephen K Ball; Vineet Mishra; Simon C Body; Nancy J Brown Journal: Crit Care Med Date: 2012-10 Impact factor: 7.598
Authors: Shaojie Chen; Willem-Jan Acou; Marcio G Kiuchi; Christian Meyer; Philipp Sommer; Martin Martinek; Alexandra Schratter; Bruno R Andrea; Zhiyu Ling; Shaowen Liu; Yuehui Yin; Gerhard Hindricks; Helmut Pürerfellner; Mitchell W Krucoff; Boris Schmidt; K R Julian Chun Journal: JAMA Netw Open Date: 2019-05-03
Authors: Thi Hai Linh Ngo; Van Ba Vu; Cong Huu Nguyen; Tien Dung Le; Trung Kien Hoang; Ben Freedman; Nicole Lowres Journal: BMJ Open Date: 2018-09-04 Impact factor: 2.692